Patient Guide: A Prospective, Non-interventional, Multinational, Observational Study With Isatuximab in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 129 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04458831
Status: ACTIVE_NOT_RECRUITING
Condition: Plasma Cell Myeloma
Phase: Research Study

Where You Can Participate

This study is available at 129 locations across the country.

Top locations include:
  • • Little Rock, Arkansas
  • • Fullerton, California
  • • San Francisco, California
  • • And 126 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Prospective, Non-interventional, Multinational, Observational Study With Isatuximab in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM) - Join Clinical Trial NCTNCT04458831

How to Join This Clinical Trial - NCTNCT04458831

Learn how to participate in this clinical trial studying an investigational therapy for Plasma Cell Myeloma. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Plasma Cell Myeloma. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Plasma Cell Myeloma
Treatment Being Tested
Investigational treatment
Study Phase
Clinical trial phase - Research study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT04458831 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 129 locations. Find a study site near you:

Clinical Research Site

Little Rock, Arkansas 72205-7199 - United States

Status: Contact for availability

Clinical Research Site

Fullerton, California 92835 - United States

Status: Contact for availability

Clinical Research Site

San Francisco, California 94143 - United States

Status: Contact for availability

Clinical Research Site

Fort Lauderdale, Florida 33308 - United States

Status: Contact for availability

Clinical Research Site

Jacksonville, Florida 32204 - United States

Status: Contact for availability

Clinical Research Site

Lakeland, Florida 33805 - United States

Status: Contact for availability

Clinical Research Site

Pembroke Pines, Florida 33024 - United States

Status: Contact for availability

Clinical Research Site

Saint Petersburg, Florida 33709 - United States

Status: Contact for availability

Clinical Research Site

Garden City, Kansas 67846 - United States

Status: Contact for availability

Clinical Research Site

Lewiston, Maine 04240 - United States

Status: Contact for availability

And 119 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this clinical trial for Plasma Cell Myeloma:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships